Patrick M. Dougherty, PhD
Department of Pain Medicine, Division of Anesthesiology, Critical Care and Pain Medicine
Present Title & Affiliation
Primary Appointment
H.E.B. Professor in Cancer Research, Department of Pain Medicine, Division of Anesthesiology and Critical Care, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Adjunct Professor, Department of Department of Neurobiology & Anatomy, The University of Texas Health Science Center, Houston, TX
Education & Training
Degree-Granting Education
| 1988 | University of Texas Graduate School of Biomedical Science, Houston, TX, USA, PHD, Biomedical Science |
| 1984 | University of Texas Medical School, Houston, TX, USA, MD, Medical |
| 1982 | University of Dallas, Irving, TX, USA, BA, Biology |
Postgraduate Training
| 1989-1992 | Research Fellowship, Department of Anatomy and Neurosciences Marine Biomedical Institute, University of Texas Medical Branch, Galveston, TX |
| 1988-1989 | Research Fellowship, Department of Neurobiology and Anatomy, University of Texas Medical School At Houston, Houston, TX |
Board Certifications
| 1984 | National Board of Medical Examiners Step 1 |
Experience & Service
Academic Appointments
Associate Professor, Department of Department of Anesthesiology and Pain Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 2000 - 2007
Associate Professor, Department of Department of Neurosurgery and Neuroscience, The John Hopkins University School of Medicine, Baltimore, MD, 1998 - 2000
Assistant Professor, Department of Departments of Neurosurgery and Neuroscience, The John Hopkins University School of Medicine, Baltimore, MD, 1992 - 1998
Other Appointments/Responsibilities
Science MD/PhD Committee, The University of Texas Graduate School of Biomedical Science, Houston, TX, 2010 - Present
Member, The University of Texas Graduate School of Biomedical Science Membership Committee, Houston, TX, 2009 - 2010
Member, The University of Texas Graduate School of Biomedical Science MD/PhD Committee, Houston, TX, 2004 - 2009
Institutional Committee Activities
Member, Institutional Animal Care and Use Committee (IACUC), 2012 - Present
Member, Cancer Survivorship Task Force, 2006 - Present
Member, Divisional Promotions Committee, 2005 - 2005
Consultantships
Member of the Scientific Review Board, Medtronic Incorporated, Minneapolis, MN, 2009 - 2011
Member of the Scientific Review Board, Microtransponder Incorporated, Dallas, TX, 2007 - 2011
Member of the Scientific Review Board, Centocor Pharmaceuticals, Horsham, PA, 2006 - 2008
Member of the Scientific Review Board, Vaporgesic Incorporated, Houston, TX, 2006 - 2011
Member of the Scientific Review Board, MGI Pharma, Bloomington, MN, 2005 - 2008
Honors & Awards
| 2009 | Outstanding Neuroscience Faculty Award, University of Texas Medical School at Houston |
| 2008 | Outstanding Neuroscience Faculty Award, University of Texas Medical School at Houston |
| 2006 | Finalist, Robert M. Chamberlin Distinguished Mentor Award, University of Texas M. D. Anderson Cancer Center |
Selected Publications
Peer-Reviewed Articles
- Cata JP, Weng HR, Dougherty PM. The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res 1229:100-110, 2008. e-Pub 2008. PMID: 18652810.
- Cata JP, Weng HR, Dougherty PM. Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy. Brain Res 1230:91-98, 2008. e-Pub 2008. PMID: 18657527.
- Cata JP, Weng HR, Dougherty PM. Spinal injection of IL-2 or IL-15 produces hyperalgesia in rats. Neurosci. Lett 437(1):45-49, 2008. e-Pub 2008. PMID: 18423867.
- Garcia JM, Cata JP, Dougherty PM, Smith RG. Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia. Endocrinology 149(2):455-460, 2008. e-Pub 2007. PMID: 17962345.
Grant & Contract Support
| Title: | Role of Glutamate Transporters in Spinal Pain Signaling |
| Funding Source: | NIH/NINDS |
| Role: | Co-Investigator |
| Title: | Mechanisms of Lymphoid Cancer-Related Chemoneuropathy Project 3 in Mechanisms of Symptoms of Multiple Myelom, Charles Cleeland, Program Director |
| Funding Source: | NCI |
| Role: | Principal Investigator |